Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label long-term lacosamide adjunctive therapy in children with epilepsy
2011-001559-35Phase 2Completed
- Sponsor
- UCB
- Start
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of lacosamide in epilepsy, sponsored by UCB. Primary endpoint: Treatment-emergent adverse events. Started Jan 2012; status: completed.
02
Drugs
lacosamide
03
Conditions
epilepsy
Beyond the preview
Go deeper on 2011-001559-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001559-35.